EMZOLAM

Main information

  • Trade name:
  • EMZOLAM 5/5 CAP
  • Dosage:
  • 100/250;MG
  • Pharmaceutical form:
  • CAP
  • Composition:
  • 5/5
  • Medicine domain:
  • Humans
  • Medicine type:
  • Allopathic drug

Documents

Localization

  • Available in:
  • EMZOLAM 5/5 CAP
    India
  • Language:
  • English

Other information

Status

  • Source:
  • Central Drugs Standard Control Organization
  • Last update:
  • 09-08-2016

29-3-2018

TEMOZOLOMIDE Capsule [AvPAK]

TEMOZOLOMIDE Capsule [AvPAK]

Updated Date: Mar 29, 2018 EST

US - DailyMed

20-2-2018

TEMOZOLOMIDE Capsule [Amneal Pharmaceuticals LLC]

TEMOZOLOMIDE Capsule [Amneal Pharmaceuticals LLC]

Updated Date: Feb 20, 2018 EST

US - DailyMed

21-11-2017

TEMOZOLOMIDE Capsule [Teva Pharmaceuticals USA, Inc.]

TEMOZOLOMIDE Capsule [Teva Pharmaceuticals USA, Inc.]

Updated Date: Nov 21, 2017 EST

US - DailyMed

1-11-2017

TEMOZOLOMIDE (Temozolomide) Capsule [Chemi Pharma LLC]

TEMOZOLOMIDE (Temozolomide) Capsule [Chemi Pharma LLC]

Updated Date: Nov 1, 2017 EST

US - DailyMed

26-10-2017

TEMOZOLOMIDE Capsule [Zydus Pharmaceuticals (USA) Inc.]

TEMOZOLOMIDE Capsule [Zydus Pharmaceuticals (USA) Inc.]

Updated Date: Oct 26, 2017 EST

US - DailyMed

26-10-2017

TEMOZOLOMIDE Capsule [Cadila Healthcare Limited]

TEMOZOLOMIDE Capsule [Cadila Healthcare Limited]

Updated Date: Oct 26, 2017 EST

US - DailyMed

7-9-2017

TEMOZOLOMIDE Capsule [Sandoz Inc.]

TEMOZOLOMIDE Capsule [Sandoz Inc.]

Updated Date: Sep 7, 2017 EST

US - DailyMed

31-7-2017

TEMOZOLOMIDE Capsule [Sun Pharma Global FZE]

TEMOZOLOMIDE Capsule [Sun Pharma Global FZE]

Updated Date: Jul 31, 2017 EST

US - DailyMed

24-5-2017

Temozolomide Accord (Accord Healthcare Limited)

Temozolomide Accord (Accord Healthcare Limited)

Temozolomide Accord (Active substance: temozolomide) - Centralised - Yearly update - Commission Decision (2017)3652 of Wed, 24 May 2017

Europe -DG Health and Food Safety

3-5-2017

Temozolomide Teva (Teva B.V.)

Temozolomide Teva (Teva B.V.)

Temozolomide Teva (Active substance: temozolomide) - Centralised - Yearly update - Commission Decision (2017) 2982 of Wed, 03 May 2017

Europe -DG Health and Food Safety